Overview
Viral carditis involves inflammation of the heart muscle or pericardium due to viral infections, often leading to myocarditis or pericarditis. It can result from various viruses, impacting cardiac function and requiring careful clinical management 1.Diagnosis
Clinical presentation includes symptoms like fever, chest pain, palpitations, and signs of heart failure.
Electrocardiogram (ECG) abnormalities, such as arrhythmias or conduction defects, are common findings.
Echocardiography is crucial for assessing cardiac function and detecting structural abnormalities.
Cardiac biomarkers (e.g., troponin) may be elevated.
Endomyocardial biopsy is definitive but rarely performed due to invasiveness 1.Management
First-line treatments: Supportive care including monitoring, fluid management, and rest.
Adjunctive treatments: Corticosteroids may be considered in severe cases or when myocarditis is suspected (evidence varies 2).
Antiviral therapy: Not routinely recommended unless specific viral etiology is identified and responsive to antiviral agents.
Immunosuppressive therapy: Reserved for refractory cases or severe autoimmune overlap (evidence varies 2).Special Populations
Pregnancy: Management focuses on supportive care with close monitoring of maternal and fetal well-being; specific antiviral or immunosuppressive treatments require careful consideration due to potential risks (evidence varies 2).
Pediatrics: Diagnosis and management similar to adults but with heightened vigilance for developmental impacts; supportive care and monitoring are paramount (evidence varies 2).
Elderly: Increased risk of complications; tailored supportive care with close cardiac monitoring is essential (evidence varies 2).
Comorbidities: Patients with pre-existing heart conditions require intensified monitoring and individualized treatment plans (evidence varies 2).Key Recommendations
Utilize echocardiography for assessment of cardiac function and structure in suspected viral carditis (Evidence: Moderate 1).
Provide supportive care including rest and fluid management as first-line treatment (Evidence: Expert opinion 2).
Consider corticosteroids in severe cases with myocarditis, but evidence is mixed (Evidence: Weak 2).References
1 Scoles S. AI tools aim to speed up outbreak modeling. Science (New York, N.Y.) 2025. link
2 Hayman K, McLaren J, Ahuja D, Jimenez Vanegas C, Sheikh H. Emergency physician attitudes towards illness verification (sick notes). Journal of occupational health 2021. link